BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.430
-0.050 (-3.38%)
May 28, 2026, 2:25 PM EDT - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $10.78 million as of May 28, 2026. Its market cap has decreased by -49.37% in one year.
Market Cap
10.78M
Enterprise Value
-1.64M
1-Year Change
-49.37%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $10.78M, a decrease of -79.26%. That is a compound annual growth rate of -24.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 11.20M | 28.74% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 12.40M |
| Kiora Pharmaceuticals | 11.97M |
| CalciMedica | 11.97M |
| Kairos Pharma | 11.07M |
| Aprea Therapeutics | 10.90M |
| BioCardia | 10.36M |
| Psyence Biomedical | 10.30M |
| GeoVax Labs | 10.10M |